Advita Ortho Debuts AI-Powered Orthopedic Solutions at AAOS 2026

  • Advita Ortho, founded November 2025, will showcase its AI-driven orthopedic technologies at AAOS 2026.
  • The company's Active Intelligence® ecosystem includes surgeon-controlled navigation and machine learning tools.
  • Key implant innovations include the Truliant® Porous Knee and advancements in the Vantage® Ankle system.
  • Predict+™, an ML-driven surgical decision-making tool, is among the featured technologies (not yet FDA-approved).

Advita Ortho's debut at AAOS 2026 underscores the accelerating integration of AI and machine learning in orthopedic surgery. The company is positioning itself as a disruptor by combining high-quality implants with data-driven surgical technologies, targeting precision and efficiency gains. Its rapid product development cycle—founded just four months prior—suggests aggressive expansion plans in a market increasingly valuing digital health solutions.

Regulatory Hurdles
Whether Predict+™ can secure FDA approval and accelerate commercialization.
Market Penetration
The pace at which Advita Ortho gains surgeon adoption for its AI-powered ecosystem.
Competitive Positioning
How Advita Ortho differentiates itself in the crowded orthopedic technology space.